Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$573M |
| 2 |
Microsoft
MSFT
|
+$529M |
| 3 |
McDonald's
MCD
|
+$469M |
| 4 |
Walt Disney
DIS
|
+$303M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$482M |
| 2 |
Comcast
CMCSA
|
+$481M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$381M |
| 4 |
Sherwin-Williams
SHW
|
+$374M |
| 5 |
CELG
Celgene Corp
CELG
|
+$341M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.22% |
| 2 | Technology | 7.41% |
| 3 | Consumer Discretionary | 6.04% |
| 4 | Financials | 5.89% |
| 5 | Industrials | 4.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5651
CALL
Lamar Advertising Co
LAMR
$14.6B
| $314K | ﹤0.01% |
4,200
-2,500
| -37% | -$188K |
2013 Q2
15 quarters
|
|
5652
PUT
Movado Group
MOV
$749M
| $314K | ﹤0.01% |
+12,600
| New | +$319K |
2017 Q1
0 quarters
|
|
|
KCG
5653
PUT
DELISTED
KCG Holdings, Inc.
KCG
| $314K | ﹤0.01% |
17,600
-24,200
| -58% | -$360K |
2013 Q3
14 quarters
|
|
5654
PUT
BOK Financial
BOKF
$7.78B
| $313K | ﹤0.01% |
+4,000
| New | +$326K |
2017 Q1
0 quarters
|
|
|
CLLS
5655
Cellectis
CLLS
$141M
| $313K | ﹤0.01% |
13,026
| – | – |
2015 Q1
8 quarters
|
|
5656
CytomX Therapeutics
CTMX
$562M
| $313K | ﹤0.01% |
+18,116
| New | +$238K |
2017 Q1
0 quarters
|
|
5657
PUT
Ericsson
ERIC
$30.5B
| $313K | ﹤0.01% |
47,200
-10,400
| -18% | -$64.2K |
2016 Q2
3 quarters
|
|
|
KYNB
5658
CALL
Kyntra Bio
KYNB
$24.4M
| $313K | ﹤0.01% |
508
-240
| -32% | -$146K |
2016 Q2
3 quarters
|
|
5659
Invesco Dorsey Wright Technology Momentum ETF
PTF
$643M
| $313K | ﹤0.01% |
20,979
-73,770
| -78% | -$1.05M |
2014 Q4
9 quarters
|
|
|
HGI
5660
DELISTED
Invesco Zacks International Multi-Asset Income ETF
HGI
| $313K | ﹤0.01% |
19,586
-19,941
| -50% | -$314K |
2016 Q3
2 quarters
|
|
5661
ProShares Ultra Silver
AGQ
$1.3B
| $312K | ﹤0.01% |
+7,567
| New | +$290K |
2017 Q1
0 quarters
|
|
5662
CorVel
CRVL
$3.82B
| $312K | ﹤0.01% |
21,528
-28,095
| -57% | -$370K |
2016 Q3
2 quarters
|
|
5663
CALL
Ultragenyx Pharmaceutical
RARE
$1.44B
| $312K | ﹤0.01% |
4,600
-3,200
| -41% | -$244K |
2015 Q2
7 quarters
|
|
5664
Trimble
TRMB
$14.2B
| $312K | ﹤0.01% |
+9,742
| New | +$301K |
2017 Q1
0 quarters
|
|
|
AVID
5665
DELISTED
Avid Technology Inc
AVID
| $312K | ﹤0.01% |
66,776
+44,808
| +204% | +$232K |
2016 Q4
1 quarter
|
|
|
COUP
5666
PUT
DELISTED
Coupa Software Incorporated
COUP
| $312K | ﹤0.01% |
+12,300
| New | +$314K |
2017 Q1
0 quarters
|
|
|
FRAN
5667
CALL
DELISTED
Francesca's Holdings Corporation
FRAN
| $312K | ﹤0.01% |
+1,692
| New | +$350K |
2017 Q1
0 quarters
|
|
|
WPG
5668
PUT
DELISTED
Washington Prime Group Inc.
WPG
| $312K | ﹤0.01% |
3,989
+911
| +30% | +$76.3K |
2016 Q4
1 quarter
|
|
5669
CALL
ProShares Trust UltraShort MSCI EAFE
EFU
$1.23M
| $311K | ﹤0.01% |
5,050
+1,500
| +42% | +$98.6K |
2016 Q4
1 quarter
|
|
5670
PUT
Fortuna Silver Mines
FSM
$3.3B
| $311K | ﹤0.01% |
59,900
+5,700
| +11% | +$33.7K |
2016 Q2
3 quarters
|
|
5671
CALL
Pegasystems
PEGA
$5.68B
| $311K | ﹤0.01% |
+14,200
| New | +$288K |
2017 Q1
0 quarters
|
|
5672
PUT
TG Therapeutics
TGTX
$7.96B
| $311K | ﹤0.01% |
26,700
+15,600
| +141% | +$112K |
2016 Q4
1 quarter
|
|
|
AMAG
5673
PUT
DELISTED
AMAG Pharmaceuticals
AMAG
| $311K | ﹤0.01% |
13,800
+2,400
| +21% | +$57.5K |
2013 Q2
15 quarters
|
|
5674
PUT
Pool Corp
POOL
$5.89B
| $310K | ﹤0.01% |
2,600
+500
| +24% | +$56K |
2016 Q4
1 quarter
|
|
|
RSO
5675
PUT
DELISTED
Resource Capital Corp.
RSO
| $310K | ﹤0.01% |
31,700
+12,900
| +69% | +$112K |
2016 Q4
1 quarter
|
|
Similar funds
Citadel Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, Citadel Advisors held 8,634 positions worth $109B, up 11% from $99B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Citadel Advisors deployed $4.43B of net new capital in Q1 2017, opening 1,445 new positions and adding to 2,647 existing holdings. Its largest new stake was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, down from 63% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $482M trimmed.
- Citadel Advisors's largest Q1 2017 buy was Meta Platforms (Facebook): 4,289,917 shares worth $609M.
- Citadel Advisors added most to Microsoft in Q1 2017, an estimated $529M increase.
- Citadel Advisors's biggest Q1 2017 reduction was Alphabet (Google) Class A, cutting an estimated $482M.
- Citadel Advisors fully exited Celgene Corp in Q1 2017, selling an estimated $341M.
- Citadel Advisors's ten largest holdings make up 19% of its $109B portfolio in Q1 2017.
- Citadel Advisors opened 1,445 new positions and closed 1,267 in Q1 2017.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $109B.
Based on Citadel Advisors's 13F filing for Q1 2017, filed 12 May 2017.